Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) today announced that it has priced an underwritten a public offering of 5,050,505 shares of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE